etoposide has been researched along with methane in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gräslund, A; Jarvet, J; Kogner, P; Lindskog, M; Spenger, C | 1 |
Bergamaschi, A; De Nicola, M; Gattia, DM; Ghibelli, L; Magrini, A; Nuccitelli, S; Traversa, E | 1 |
Agarwal, R; Ali, N; Biris, AR; Biris, AS; Dervishi, E; Fejleh, A; Galanzha, EI; Iancu, C; Iancu, DT; Karmakar, A; Li, Z; Mahmood, M; Mocan, L; Mocan, T; Xu, Y; Zharov, VP | 1 |
Chen, C; Ji, XM; Liu, YQ; Tao, Q; Wang, QL; Xie, XX; Yu, SQ; Zhang, FY; Zhou, Q; Zou, Y | 1 |
Ali, S; Biris, A; Casciano, D; Dantuluri, V; Karmakar, A; Mahmood, M; Mustafa, T; Xu, Y; Zhang, Y | 1 |
Adam, V; Balvan, J; Dostalova, S; Heger, Z; Krizkova, S; Masarik, M; Moulick, A; Polanska, H; Raudenska, M | 1 |
6 other study(ies) available for etoposide and methane
Article | Year |
---|---|
Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Choline; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Hydrocarbons; Irinotecan; Magnetic Resonance Spectroscopy; Matched-Pair Analysis; Methane; Neuroblastoma; Predictive Value of Tests; Protons; Rats; Rats, Nude; Reproducibility of Results; Transplantation, Heterologous | 2004 |
Effects of carbon nanotubes on human monocytes.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cytotoxins; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Humans; Leukocytes, Mononuclear; Monocytes; Nanotubes, Carbon; Necrosis | 2009 |
Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Synergism; Etoposide; Flow Cytometry; HeLa Cells; Humans; Microscopy, Electron, Transmission; Nanotubes, Carbon; Neoplasms | 2009 |
EGF-functionalized single-walled carbon nanotubes for targeting delivery of etoposide.
Topics: Antineoplastic Agents; Binding, Competitive; Cell Death; Cell Line, Tumor; Drug Delivery Systems; Epidermal Growth Factor; Etoposide; Humans; Nanotubes, Carbon; Spectrophotometry, Ultraviolet; Spectrum Analysis, Raman; Thermodynamics | 2012 |
Carbon nanotubes enhance the internalization of drugs by cancer cells and decrease their chemoresistance to cytostatics.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cytostatic Agents; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Humans; Metabolic Clearance Rate; Nanostructures; Nanotubes, Carbon; Pancreatic Neoplasms; Treatment Outcome | 2013 |
Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancer.
Topics: Antineoplastic Agents; Apoptosis; Biocompatible Materials; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Drug Carriers; Drug Synergism; Electrophoresis; Erythrocytes; Etoposide; Flow Cytometry; Hemolysis; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Lung Neoplasms; Microscopy, Electron, Scanning; Nanotubes, Carbon; Nucleic Acids; Oligonucleotides; Oligonucleotides, Antisense; Polyethylene Glycols; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Small Cell Lung Carcinoma | 2017 |